1876 individuals with screen-detected diabetes and a mean age of 66 years underwent assessment of self-reported health status ( SF-36 ) , diabetes-specific QoL ( the Audit of Diabetes Dependent Quality of Life ( ADDQoL19 ) ) and glycated haemoglobin ( HbA1c ) at five years post-diagnosis in the ADDITION-Europe trial .